Eton Pharmaceuticals Licenses US Rights to Aquestive's Epilepsy Drug

MT newswire2026/10/14 11:15

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

07:15 AM EDT, 10/14/2026 (MT Newswires) -- Eton Pharmaceuticals (ETON) said Wednesday that it has signed an exclusive US licensing and supply agreement with Aquestive Therapeutics (AQST) for Aquestive's Libervant buccal film, a treatment for seizure clusters in patients with epilepsy. Eton said it expects the product to be commercially available in April. Eton said the deal expands its rare disease portfolio into neurology, with Aquestive supplying the product and Eton handling US commercialization and drawing on its specialty drug sales and patient support capabilities.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26